Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-16 Yu K Peony Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −3,750 56,250
2020-03-16 Cotroneo Pat SVP, Finance and CFO Sale −9,239 $26.36 $244K 236,466
2020-03-06 Chung Christine SVP, China Operations Shares withheld for taxes −10,126 $39.71 $402K 122,518
2020-03-06 Yu K Peony Chief Medical Officer Shares withheld for taxes −9,826 $39.71 $390K 162,791
2020-03-06 Kouchakji Elias SVP, Clinical Dev, Drug Safety Shares withheld for taxes −6,525 $39.71 $259K 94,691
2020-03-06 Cotroneo Pat SVP, Finance and CFO Shares withheld for taxes −4,881 $39.71 $194K 245,705
2020-02-12 Chung Christine SVP, China Operations Exercise or conversion +5,625 $25.40 $143K 138,269
2020-02-12 Chung Christine SVP, China Operations Sale −5,025 $45.94 $231K 133,244
2020-02-12 Chung Christine SVP, China Operations Sale −600 $46.28 $28K 132,644
2020-02-12 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −5,625 42,464
2020-02-11 Chung Christine SVP, China Operations Exercise or conversion +5,625 $25.40 $143K 138,269
2020-02-11 Chung Christine SVP, China Operations Sale −5,625 $44.48 $250K 132,644
2020-02-11 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −5,625 48,089
2020-02-10 Kurkijarvi Kalevi Director Exercise or conversion +6,000 $18.34 $110K 34,400
2020-02-10 Kurkijarvi Kalevi Director Sale −6,000 $42.69 $256K 28,400
2020-02-10 Kurkijarvi Kalevi Director Exercise or conversion · Stock Option (Right to Buy) −6,000 6,000
2020-01-07 Chung Christine SVP, China Operations Exercise or conversion +5,625 $25.40 $143K 138,269
2020-01-07 Chung Christine SVP, China Operations Sale −5,625 $42.76 $241K 132,644
2020-01-07 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −5,625 53,714
2020-01-06 Schoeneck James A Interim President Shares withheld for taxes −10,928 $43.35 $474K 22,422

Page 23 of 33 · 651 trades